Note: Ingredients listed on restricted chemical lists
EC/CAS
202-785-7/99-76-3
Name of the chemical
4-hydroxybenzoic acid, methyl ester
Concentration
*
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
*
General Information
Version
3.0
Revision date
2012-02-03
Product name
Atipamezole hydrochloride sterile injectable solution
Product name
Atipamezole hydrochloride sterile injectable solution
Identification on the label/Trade name
ANTISEDAN; ALZANE
Chemical name
Mixture
1.2.1 Relevant identified uses
Veterinary product used as anti-sedation agent
Emergency telephone
1-800-424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
Pfizer Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
Section 2
SECTION 2: Hazards identification
Appearance Clear aqueous solution in multiple-dose vials
Hazard statements
Non-hazardous in accordance with international standards for workplace safety.
Additional information
Short Term May cause nervous system and cardiovascular system effects. Known Clinical Effects Administration of atipamezole causes transient changes in heart rate and blood pressure. Clinical use of this drug has caused nervousness, excitation, vomiting, diarrhea. EU Indication of danger Not classified Australian Hazard Classification (NOHSC): Note Non-Hazardous Substance. Non-Dangerous Goods. This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
